Lyell Immunopharma Inc (LYEL)
2.045
-0.06
(-3.08%)
USD |
NASDAQ |
Jun 25, 16:00
2.045
0.00 (0.00%)
After-Hours: 20:00
Lyell Immunopharma 30-Day Average Daily Volume: 709589.9 for June 25, 2024
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| June 25, 2024 | 709589.9 |
| June 24, 2024 | 719424.5 |
| June 21, 2024 | 742892.9 |
| June 20, 2024 | 705759.0 |
| June 18, 2024 | 723834.5 |
| June 17, 2024 | 738541.4 |
| June 14, 2024 | 732724.2 |
| June 13, 2024 | 742730.4 |
| June 12, 2024 | 645876.6 |
| June 11, 2024 | 645786.4 |
| June 10, 2024 | 645146.4 |
| June 07, 2024 | 641331.7 |
| June 06, 2024 | 650509.9 |
| June 05, 2024 | 667451.5 |
| June 04, 2024 | 670695.6 |
| June 03, 2024 | 683939.5 |
| May 31, 2024 | 699140.3 |
| May 30, 2024 | 707717.1 |
| May 29, 2024 | 725356.5 |
| May 28, 2024 | 749913.4 |
| May 24, 2024 | 806377.7 |
| May 23, 2024 | 873148.9 |
| May 22, 2024 | 876131.9 |
| May 21, 2024 | 885537.7 |
| May 20, 2024 | 906007.8 |
| Date | Value |
|---|---|
| May 17, 2024 | 892886.9 |
| May 16, 2024 | 869503.2 |
| May 15, 2024 | 868576.9 |
| May 14, 2024 | 868446.0 |
| May 13, 2024 | 871496.4 |
| May 10, 2024 | 885292.8 |
| May 09, 2024 | 902833.6 |
| May 08, 2024 | 888664.2 |
| May 07, 2024 | 876207.0 |
| May 06, 2024 | 862375.1 |
| May 03, 2024 | 850460.3 |
| May 02, 2024 | 865942.0 |
| May 01, 2024 | 867188.7 |
| April 30, 2024 | 911021.6 |
| April 29, 2024 | 912125.0 |
| April 26, 2024 | 949593.0 |
| April 25, 2024 | 972239.0 |
| April 24, 2024 | 985802.3 |
| April 23, 2024 | 985753.3 |
| April 22, 2024 | 987856.7 |
| April 19, 2024 | 978428.7 |
| April 18, 2024 | 967055.6 |
| April 17, 2024 | 957921.6 |
| April 16, 2024 | 946877.3 |
| April 15, 2024 | 930720.0 |
30-Day Average Daily Volume Range, Past 5 Years
199549.2
Minimum
Sep 02 2021
1.969M
Maximum
Mar 23 2022
935875.1
Average
911200.6
Median
Mar 01 2024
30-Day Average Daily Volume Benchmarks
| GlycoMimetics Inc | 5.007M |
| Candel Therapeutics Inc | 825020.8 |
| Eliem Therapeutics Inc | 110344.7 |
| Entrada Therapeutics Inc | 84819.40 |
| NovaBay Pharmaceuticals Inc | 557903.6 |